Hints and tips:
...Brian Costell, a neurologist at First Choice Neurology in Boca Raton, Florida, and is one of the most prolific prescribers of Leqembi, said he did not understand why the FDA was “pushing the brakes” on donanemab...
...investment in King’s Cross will help researchers at MSD, known as Merck in the US, work closely with academics to do the early science necessary for creating new treatments for huge unmet needs in areas such as neurology...
...“That sounds unpleasant but it isn’t when done by skilled hands,” said Chris McDermott, professor of translational neurology at Sheffield university....
...It has also narrowed its focus on two therapeutic areas: oncology and neurology....
...While this study is a welcome development, it does not prove the amyloid hypothesis,” said Alberto Espay, professor of neurology at the University of Cincinnati....
...Alberto Espay, professor of neurology at the University of Cincinnati, said some researchers had become far too tethered to the amyloid hypothesis, which has been tested in dozens of studies that have failed...
...Alberto Espay, professor of neurology at the University of Cincinnati, said that “literally every study we’ve done” had disproven the amyloid hypothesis but nevertheless it “has survived every evidence to...
...Joel Perlmutter, a professor of neurology at the Hope Center for Neurological Disorders, accused the FDA of trying to present the data to the panel as if “there was a bias in that one direction”....
...The remainder of the pharmaceutical group, which will still be known as Bausch Health, will focus on gastroenterology, aesthetics, dermatology and neurology....
...Mr Hudson also announced a simplification of Sanofi’s structure, with four core global business units to be reduced to three: speciality care covering immunology, rare diseases, rare blood disorders, neurology...
...Stephen Salloway, a professor of psychiatry, human behaviour and neurology at Brown University, said the study was an important start — a “biological foothold” for the fight against Alzheimer’s....
...However, Biogen’s drug looked more promising after a paper published in Nature in 2016 showed that in a small drug, there was “a fairly meaningful stabilisation”, said Dr Adam Boxer, a professor in neurology...
...After it closed, he set up Donda’s House, named after his mother, but which is now known as Art of Culture Inc, this time to support creativity in young people in Chicago....
...I had more or less abandoned the dream and accepted the need to haul a traditional laptop everywhere when in 2007 I met a New York University professor of neurology, Elkhonon Goldberg, who used old Psions...
...“However, we believe that the fight against Alzheimer’s and other important areas of unmet need in neurology is too important to be derailed by this setback.”...
...(Telegraph) Treatment of depression Could a new field of ‘immuno-neurology’ be on the horizon?...
...Drug company Regeneron Pharmaceuticals was one of the biggest gainers, rising 5.4 per cent to $522.02; Biogen, which focuses on neurology, oncology and immunology treatment, jumped 4.7 per cent to $278.60...
...In 2009, I interviewed a New York neurology professor, Elkhonon Goldberg, who liked to work on refurbished Psion 5s sourced from the UK....
...GLG had introduced Martoma to Sidney Gilman, a neurology professor involved in the Alzheimer’s drug trials....
...But a key impetus is demand from patients with more complex medical needs, particularly in oncology and neurology, as private hospitals become increasingly involved in more complex procedures....
...Ray Dorsey, professor of neurology at New York state’s University of Rochester Medical Center, which is leading the Parkinson’s study, said ResearchKit had opened the way to “inexpensive, high-quality clinical...
...The company had produced six consecutive years of strong revenue and profit growth by selling products in oncology, cardiology, respiratory, neurology and gastroenterology....
...It is a long time since we’ve seen positive results of this type in a trial for Alzheimer’s disease,” said Thomas Wisniewski, neurology professor at New York University’s School of Medicine, who was at the...
...New York-based Forest has long been viewed as a likely target because its development pipeline dovetails with AstraZeneca’s in areas such as neurology and respiratory treatments....
...Medtronic plans in future to provide similar long-term hospital management services for cardiac surgery, neurology and spinal operations, all areas where it already produces medical devices....
International Edition